摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

S22701

中文名称
——
中文别名
——
英文名称
S22701
英文别名
N-(4-METHOXY-2,3-DIHYDRO-1H-PHENALEN-2-YL)PROPIONAMIDE;N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)propanamide
S22701化学式
CAS
——
化学式
C17H19NO2
mdl
——
分子量
269.343
InChiKey
AFVZJQYIPSPCKZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    4-methoxy-2,3-dihydro-1H-phenalene-2-carboxylic acid盐酸 、 sodium azide 、 三乙胺 作用下, 以 二氯甲烷丙酮甲苯 为溶剂, 反应 5.42h, 生成 S22701
    参考文献:
    名称:
    Melatonergic Properties of the (+)- and (−)-Enantiomers of N-(4-Methoxy-2,3-dihydro-1H-phenalen-2-yl)amide Derivatives
    摘要:
    N-(4-Methoxy-2,3-dihydro- 1H-phenalen-2-yl)amide derivatives, conformationally restricted ligands for melatonin receptors, were synthesized by an alternative synthetic method from the corresponding 1,8-naphthalic anhydride which was transformed into the phenalenecarboxylic acid 7. A Curtius reaction on 7 gave the amino compound which was acylated to give compounds 4a-c. The (+)- and (-)-4a-c enantiomers were separated by semipreparative chiral HPLC. Compounds were evaluated for their affinity for chicken brain melatonin receptors in binding assays using 2-[I-125]iodomelatonin and for their potency to light;en the skin of Xenopus laevis tadpoles. The butyramido derivative 4c was the most potent ligand (K-i = 1.7 nM). No enantioselectivity was observed with the enantiomers which were equipotent to the racemic mixture. In contrast to the reference compounds, melatonin, agomelatine (S 20098), and N-[2-(2,7-dimethoxynaphth-1-yl)ethyl]acetamide, which were very potent at Lightening the skin of X. laevis tadpoles, compounds 4a-c were inactive or weakly active (EC50 > 1 mu M). In this bioassay, compound 4a was characterized as a putative antagonist of melatonin receptors.
    DOI:
    10.1021/jm9804937
点击查看最新优质反应信息

文献信息

  • Synthesis of 2-Amido-2,3-dihydro-1<i>H</i>-phenalene Derivatives as New Conformationally Restricted Ligands for Melatonin Receptors
    作者:Monique Mathé-Allainmat、Florence Gaudy、Sames Sicsic、Anne-Laure Dangy-Caye、Shuren Shen、Béatrice Brémont、Zohra Benatalah、Michel Langlois、Pierre Renard、Philippe Delagrange
    DOI:10.1021/jm960219h
    日期:1996.1.1
    Tetrahydroanthracene, tetrahydrophenanthrene, and tetrahydrophenalene moieties were used to design novel constrained melatoninergic agents. Compounds 1 and 2 were synthesized from the cyclization of the aryl succinic acids 6a,b followed by catalytic reduction, Curtius degradation to the amino derivatives, and acetylation. The phenalene derivatives 3 were prepared by cyclization of the aza lactones of the corresponding alpha-N-acetyl amino acids. The ketone derivatives were reduced directly by catalytic hydrogenation to produce the compounds 3. The different compounds were evaluated in vitro in binding assays using 2-[I-125]iodomelatonin and chicken brain membranes. Melatonin and 2-acetamido-8-methoxytetralin were used as the reference compounds. The results showed the superiority of the dihydrophenalene framework 3 over tho se of tetrahydro anthracene and tetrahydrophenanthrene. 3a had relatively good affinity for melatonin receptors (K-i = 28.7 nM). Introduction of an additional methoxy group gave a derivative (3c) with nanomolar affinity (K-i = 0.7 nM), confirming the existence of a secondary binding site in the receptor which has been described previously. An increase in the affinity was also observed with the propionamido derivative 3e (K-i = 6.0 nM). The potential agonist properties of the compound 3e were evaluated on the dermal melanocytes of Xenopus laevis tadpoles. At the concentration of 2.3 nM (5 x K-i), melatonin gave melanophore index value of 1. Similarly to melatonin, 3e was shown to be a potent agonist of the melanosome aggregation.
  • Melatonergic Properties of the (+)- and (−)-Enantiomers of <i>N</i>-(4-Methoxy-2,3-dihydro-1<i>H</i>-phenalen-2-yl)amide Derivatives
    作者:Carole Jellimann、Monique Mathé-Allainmat、Jean Andrieux、Pierre Renard、Philippe Delagrange、Michel Langlois
    DOI:10.1021/jm9804937
    日期:1999.3.1
    N-(4-Methoxy-2,3-dihydro- 1H-phenalen-2-yl)amide derivatives, conformationally restricted ligands for melatonin receptors, were synthesized by an alternative synthetic method from the corresponding 1,8-naphthalic anhydride which was transformed into the phenalenecarboxylic acid 7. A Curtius reaction on 7 gave the amino compound which was acylated to give compounds 4a-c. The (+)- and (-)-4a-c enantiomers were separated by semipreparative chiral HPLC. Compounds were evaluated for their affinity for chicken brain melatonin receptors in binding assays using 2-[I-125]iodomelatonin and for their potency to light;en the skin of Xenopus laevis tadpoles. The butyramido derivative 4c was the most potent ligand (K-i = 1.7 nM). No enantioselectivity was observed with the enantiomers which were equipotent to the racemic mixture. In contrast to the reference compounds, melatonin, agomelatine (S 20098), and N-[2-(2,7-dimethoxynaphth-1-yl)ethyl]acetamide, which were very potent at Lightening the skin of X. laevis tadpoles, compounds 4a-c were inactive or weakly active (EC50 > 1 mu M). In this bioassay, compound 4a was characterized as a putative antagonist of melatonin receptors.
查看更多

同类化合物

迫萘合環己-1,3-二酮 赫金青霉素 萘嵌苯酮 富拉烯酮 9-羟基-萘嵌苯-1-酮 9-甲基氨基-萘嵌苯-1-酮 9-巯基-萘嵌苯-1-酮 9-去甲基FR-901235 9-二甲基氨基-1H-萘嵌苯-1-酮 9-丁氧基-1H-萘嵌苯-1-酮 6b,7a-二氢-7H-环丙并[a]苊烯-7-胺盐酸盐(1:1) 6-羟基-3-甲基-1H-萘嵌苯-1-酮 6-羟基-1H-萘嵌苯-1-酮 6-溴-1H-萉 6-氨基-1-萉酮 3-羟基-1H-PHENALEN-1-酮 2-甲氧基非那烯酮 2-甲基-1-氧代-1H-非那烯-3-乙酸 2-氯-6-(3-羟基丙基)氨基-1H-萉-1-酮 2,3-二氢-6-甲氧基萘嵌苯-1-酮 2,3-二氢-1H-萉 2,3-二氢-1H-苯并-1-酮 1H-非那烯并[2,1-d][1,3]噻唑 1H-非那烯 1H-萘嵌苯-1-酮腙 1-硫酮-9-甲基氨基-非那烯 (R)-8,9-二氢-4,5,6,7-四羟基-1,8,8,9-四甲基-3H-非那烯并(1,2-b)呋喃-3-酮 2-hydroxy-2-piperidino-phenalene-1,3-dione 9-[(4-pyrimidin-2-yl)piperazin-1-yl]-1H-phenalen-1-one N-[2-(4,9-dimethoxy-2,3-dihydro-1H-1-phenalenyl)ethyl]butanamide N-[2-(9-methoxy-2,3-dihydro-1H-1-phenalenyl)ethyl]butanamide 9-methyl-9-(2-methylpropenyl)-8,9-dihydrophenaleno[1,2-b]furan-7-one 3-((cyclohexylmethyl)amino)-6-(cyclohexylthio)-1-oxo-1H-phenalene-2-carbonitrile 9-(4-benzylpiperazin-1-yl)-1H-phenalen-1-one perchlorophenalenyl radical 6-((4-bromophenyl)thio)-1-oxo-1H-phenalene-2,3-dicarbonitrile methyl 3-((6-((4-bromophenyl)thio)-2-cyano-1-oxo-1H-phenalen-3-yl)amino)propanoate 3-((6-((4-bromophenyl)thio)-2-cyano-1-oxo-1H-phenalen-3-yl)amino)propanoic acid 3-((6-((4-bromophenyl)thio)-2-cyano-1-oxo-1H-phenalen-3-yl)amino)-N-(2-(2-hydroxyethoxy)ethyl)propanamide 1,1-dimethyl-1a,11b-dihydro-1H-benzo[k]cyclopropa[4,5]cyclopent[1,2,3-cd]fluoranthene 6-(cyclopentylthio)-1-oxo-1H-phenalene-2,3-dicarbonitrile 5-propyl-9-hydroxyphenalenone N-[2-(4,9-dimethoxy-2,3-dihydro-1H-1-phenalenyl)ethyl]propanamide N-[2-(4-methoxy-2,3-dihydro-1H-1-phenalenyl)ethyl]propanamide N-benzyl-1,2,3,10-tetrahydronaphtho[1,8-fg]indol-7-yl trifluoromethanesulfonate N-benzyl-7-ethyl-1,2,3,10-tetrahydronaphtho[1,8-fg]indole 1-oxo-1H-phenalene-2,3-dicarbonitrile 1-((1-oxo-1H-phenalen-2-yl)methyl)pyridinium chloride 9-[(2-hydroxyethyl)(methyl)amino]-1H-phenalen-1-one 6-phenylsulfanyl-2,3-dicyanophenalenone